PRESS RELEASE published on 02/17/2025 at 12:00, 1 year 6 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social VALBIOTIS SA publie des informations mensuelles sur le nombre total de droits de vote et d'actions en circulation. L'entreprise est spécialisée dans les compléments alimentaires pour la prévention des maladies cardiovasculaires Droits De Vote Capital Social Compléments Alimentaires Maladies Cardiovasculaires Valbiotis SA
BRIEF published on 01/30/2025 at 17:45, 1 year 6 months ago Valbiotis to Launch Valbiotis®PRO Metabolic Health in February Valbiotis Metabolic Health Dietary Supplement TOTUM•63 France Launch
BRIEF published on 01/30/2025 at 17:45, 1 year 6 months ago Valbiotis lance Valbiotis®PRO Metabolic Health en février Valbiotis Santé Métabolique Complément Alimentaire TOTUM•63 Lancement En France
PRESS RELEASE published on 01/30/2025 at 17:40, 1 year 6 months ago VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, Valbiotis®PRO Metabolic Health (Totum•63), on February 3rd Valbiotis announces the market launch of Valbiotis®PRO Metabolic Health (Totum•63) in France on February 3rd, providing a natural, plant-based solution for metabolic diseases Valbiotis Metabolic Diseases Metabolic Health Dietary Supplement TOTUM•63
PRESS RELEASE published on 01/30/2025 at 17:40, 1 year 6 months ago VALBIOTIS SA: Valbiotis commercialisera dès le 3 février prochain sa solution Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques Valbiotis SA va commercialiser Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques à partir du 3 février, basée sur TOTUM•63 et stratégie multicanal Valbiotis SA TOTUM•63 Valbiotis®PRO Santé Métabolique Prévention Maladies Métaboliques Stratégie Multicanal
BRIEF published on 01/21/2025 at 17:45, 1 year 6 months ago Valbiotis Outlines 2030 Strategic and Financial Targets Financial Targets Valbiotis International Sales 2030 Goals Cardiometabolic
BRIEF published on 01/21/2025 at 17:45, 1 year 6 months ago Valbiotis présente ses objectifs stratégiques et financiers à horizon 2030 Objectifs Financiers Valbiotis Ventes Internationales Objectifs 2030 Cardiométabolique
PRESS RELEASE published on 01/21/2025 at 17:40, 1 year 6 months ago VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030 Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented Valbiotis Strategic Goals International Sales Financial Goals Product Releases
PRESS RELEASE published on 01/21/2025 at 17:40, 1 year 6 months ago VALBIOTIS SA: Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 avec trois produits pour la prise en charge des troubles cardio-métaboliques sur le marché en France dès 2025 Commercialisation Valbiotis Ambitions Stratégiques Financières Cardio-métaboliques
BRIEF published on 01/14/2025 at 17:49, 1 year 7 months ago Valbiotis Announces Success in HEART II Study on Lipidrive Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
Published on 08/20/2026 at 15:30, 2 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/20/2026 at 15:15, 17 minutes ago Reporting Results for the Six Months Ended June 30, 2026
Published on 08/20/2026 at 15:00, 32 minutes ago Portfolio Update - Strategic Investment in Maravilla Oil and Gas
Published on 08/20/2026 at 15:00, 32 minutes ago Vox Royalty Enters into Binding Agreement to Acquire Australian Copper and Gold Royalty Portfolio
Published on 08/20/2026 at 14:35, 57 minutes ago Wi2Wi Reports 59% Revenue Growth to US$2.32M and Returns to Profitability with US$251K Net Income in Q2 2026
Published on 08/20/2026 at 15:10, 21 minutes ago CNTE Supplies 6.9MW/14.9MWh Energy Storage Solution for Agrosuper's San Vicente Plant in Chile
Published on 08/20/2026 at 14:35, 56 minutes ago Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $389 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
Published on 08/20/2026 at 14:33, 58 minutes ago PLANOPTIK AG: Half-Yearly Financial Report as of June 30, 2026
Published on 08/20/2026 at 14:10, 1 hour 21 minutes ago adesso extends Andreas Prenneis’s Executive Board contract through 2030 / Supervisory Board values his operational experience
Published on 08/20/2026 at 14:07, 1 hour 24 minutes ago EQS-Adhoc: PROPOSED DISTRIBUTION OF INTERIM DIVIDEND AND ADJUSTMENT TO CONVERSION PRICE OF HK$11,765,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2030(the “2025 Convertible Bonds”)
Published on 08/18/2026 at 18:00, 1 day 21 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 21 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 4 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 4 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 19 hours ago Aéroports de Paris S.A - July 2026 traffic figures